Fat-Shrinking Peptide: FDA GRAS-certified and integrated into food product concepts.
Cosmetic Products: Cosmetics with our skin-penetrating peptide growth factors as key active ingredients already in market
Pet Food: Weight-control formula developed in partnership with a pet food company.
A cutting-edge startup spun out of the University of Arizona, we are dedicated to advancing longevity and healthy living through science-driven innovations in Nutraceuticals and Cosmeceuticals.
Science-Driven Market Leadership: Leveraging bio-inspired active delivery technology to dominate billion-dollar markets through weight management, anti-aging skincare, and advanced haircare.
Nutraceuticals: Revolutionizing nutrition with state-of-the-art delivery technologies for bioactive molecules
Cosmeceuticals: Delivering scientifically validated, market-ready skincare and haircare solutions
Forever Paws: Boosting immune system, balancing physiological conditions, and weight control
Our mission is to revolutionize longevity and elevate beautiful living through innovative, science-driven solutions that harness the body’s natural rejuvenating mechanisms. By leveraging groundbreaking delivery technologies and ensuring easy accessibility, we empower individuals and families - including their cherished "forever paws” - to live healthier, more vibrant lives. Our products seamlessly integrate into everyday foods, cosmetics, and lifestyle choices, making wellness effortless and transformative.
Professor of Surgery, Director, Heart and Vascular Service Line, Baystate Health
Over 30 years clinical/translational research
Former - Senior Research Scientist at Univ. of Utah and Univ. of Arizona, CEO at DianaJCosmetics
Over 10 years of translational research, over 5 years of nutraceutical and cosmeceutical industry leadership
Associate Professor: BME at University of North Texas
Over 17 years basic/translational research in metabolic, cardiovascular diseases, regenerative medicine, oncology
Chairman of the Board: Avec Holdings, CEO: Dimension Marketing and Sales
Over 19 years in food industry leadership
Excess sugar consumption is the primary driver of modern obesity, yet current therapies like GLP-1 agonists are off-target and do not directly address sugar metabolism
A strategy that specifically controls sugar metabolism and prevents its conversion into lipids in adipocytes
A breakthrough peptide that inhibits sugar accumulation in adipocytes, blocks its conversion to lipids, and promotes efficient sugar metabolism—offering a direct and effective approach to combat obesity
*Pre-clinical evaluation for 14 days in female (Male given LLS: -16%) rodents at maximum tolerated dose. Amlexanox and AOD9604 are peptides known for fat burning. This comparison is from different studies. LLS data is generated by a third-party research organization, TOXI-COOP ZRT, following OECD Guidelines for Testing of Chemicals and US FDA Toxicological Principles. Amlexanoxreference: Nat Med. 2013 Mar;19(3):313-21, AOD9604 reference: Endocrinology 142(12):5182–5189. AOD9604 is one of the few FDA GRAS approved peptides. Administration routes: LLS peptide-Oral, Amlexanox and AOD9604 syringe injection.
**Food processing efficiency=g food consumed/g body weight gain. Higher number indicates that body processes the food consumed more efficiently through increased energy expenditure, expedited elimination, and/or reduced accumulation, etc. For example, food processing efficiency=1.0 indicates the 100% of food consumed goes to body weight.
Pre-clinical studies showed LLS peptideTM to decrease body weight gain by 45% over 30 days
Pre-clinical evaluation showed LLS peptideTM to lower blood glucose levels by 15% (validated by Novo Nordisk)
Pre-clinical studies showed LLS peptideTM to boost the immunity more than six times and regress the tumor growth by 33%
Unique features of LLS peptideTM allows production of various merchandises, cosmetics, dietary supplements, beverages, dry foods, pet foods, even pharmaceutics
LLS peptideTM has been mentioned in multiple Top-Tier Scientific Journalsincluding Nature Materials (2014, 13, 1157) and Pharmaceutics (2021, 13, 1279).
Backed by rigorous safety evaluations, our FDA GRAS-certified ingredients guarantee trust and accessibility, distinguishing us from less regulated competitors
Bioactive molecules including growth factors and peptides are large molecules that struggle to penetrate the skin barrier and are inherently unstable in cosmetic formulations
A strategy that enhances active ingredient penetration, enables targeting the right cells, and boosts stability could revolutionize the industry
A groundbreaking transdermal delivery technology enabling biomimetic peptides to penetrate the skin, activate key signaling pathways, and rejuvenate cells, the extracellular matrix, and overall skin health - redefining skincare innovation
Sign up to hear from us.